- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Diabetes Mellitus, Type 2. Physiology of Glucose Kinetics in New Zealand
Total 1380 results
-
PfizerTerminated
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States
-
NovartisCompletedDiabetes Mellitus, Type 2United States
-
NovartisCompletedDiabetes Mellitus, Type 2United States
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States
-
Forest LaboratoriesPhenomixTerminatedDiabetes Mellitus, Type IIUnited States, Belarus, Colombia, Hungary, India, Lithuania, Peru, Romania
-
Intarcia TherapeuticsCompletedType 2 DiabetesFinland, United States, Bulgaria, Poland, South Africa, Denmark, Turkey, Slovakia, Germany
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States
-
AstraZenecaQuintiles, Inc.CompletedType 2 DiabetesUnited States, Korea, Republic of, India, Russian Federation, Brazil, Mexico, South Africa, Philippines
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusSpain, Poland, South Africa, Taiwan, Hong Kong, Norway, Italy, Bulgaria, Latvia, Lithuania, Germany, Turkey, Argentina, Israel, Korea, Republic of, Dominican Republic, Guatemala, Brazil, Colombia, Peru, Philippines, Russian Federation and more
-
MedImmune LLCCompletedType 2 Diabetes MellitusGermany
-
Eli Lilly and CompanyCompletedDiabetic Neuropathies | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Insulin-DependentUnited States, Spain, Hungary, Australia, Belgium, Denmark, Estonia, Germany, Israel
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingType 2 Diabetes Mellitus | Obesity, Childhood | Impaired Glucose Tolerance | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Eli Lilly and CompanyRecruitingDiabetes Type 2United States, India, Mexico, Puerto Rico
-
Columbia UniversityCompletedDiabetes Mellitus, Type 2United States
-
National Institute of Diabetes and Digestive and...Completed
-
VeraLight, Inc.CompletedDiabetes Mellitus, Non-Insulin DependentUnited States
-
NovartisCompletedVildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 DiabetesDiabetes Mellitus, Type 2United States, Germany
-
Robert LodderUniversity of KentuckyCompleted
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
GI DynamicsTerminatedObesity | Type 2 DiabetesUnited States
-
Informed Data Systems, Inc.Mannkind CorporationUnknownDiabetes Mellitus, Type 2United States
-
Eli Lilly and CompanyActive, not recruitingType 2 Diabetes | T2DUnited States, Mexico, Argentina, Puerto Rico
-
AstraZenecaCompletedType 2 DiabetesMexico, United States, Poland, Canada, Russian Federation, South Africa, France, Hungary, India, United Kingdom
-
Albert Einstein College of MedicineWithdrawnGlucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Glucose, High BloodUnited States
-
Eli Lilly and CompanyCompletedType 2 DiabetesChina, Australia, Korea, Republic of, India
-
AstraZenecaCompletedType 2 DiabetesUnited States, Puerto Rico, Mexico, Russian Federation, Romania, Poland, Czech Republic, United Kingdom
-
Intarcia TherapeuticsCompletedType 2 DiabetesUnited States, Croatia, Latvia, Denmark, Germany
-
AstraZenecaCompletedType 2 DiabetesKorea, Republic of, Mexico, South Africa, United States, Canada, Puerto Rico, Poland, Romania
-
Stewart HarrisSanofiCompletedDiabetes Mellitus, Type 2 | Hypoglycemia | Diabetes Mellitus, Type 1United States
-
Novo Nordisk A/SRecruitingDiabetes, Type 2United States, India, Spain, Poland, South Africa, Bulgaria, Germany, Japan, Puerto Rico
-
Merck Sharp & Dohme LLCPfizerActive, not recruitingType 2 Diabetes MellitusUnited States, Belgium, Canada, Colombia, Costa Rica, Dominican Republic, France, Guatemala, Hungary, Israel, Italy, Malaysia, Mauritius, Mexico, Philippines, Poland, Russian Federation, Saudi Arabia, Turkey, Ukraine, United Arab... and more
-
NYU Langone HealthNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Healthcare Innovation Technology LabNovo Nordisk A/SUnknownDiabetes Mellitus, Type 2United States
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States, Germany
-
Yale UniversityNational Institute on Minority Health and Health Disparities (NIMHD); Hartford... and other collaboratorsCompletedDiabetes Mellitus, Type 2United States
-
GlaxoSmithKlineTerminated
-
SanofiWithdrawnDiabetes Mellitus, Type 2United States
-
PfizerTerminatedDiabetes Mellitus, Type 2United States
-
SanofiTerminated
-
SanofiCompletedDiabetes Mellitus, Type 2United States
-
NovartisCompletedType 2 Diabetes MellitusRussian Federation, Germany, United States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, United Kingdom, Australia, Canada, Thailand, India
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States, Germany
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesMexico, United States, Argentina, Brazil, Canada
-
GlaxoSmithKlinePPDCompletedDiabetes Mellitus, Type 2Spain, Germany, Hungary, Italy, Philippines, France, United States, Mexico, Brazil, South Africa, Korea, Republic of, Canada, Poland, United Kingdom
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Hungary, Poland, Slovakia, Puerto Rico
-
Columbia UniversityNational Institute on Aging (NIA); Hebrew Home at RiverdaleEnrolling by invitationDiabetes Mellitus, Type 2 | Pre-diabetesUnited States